Inmolecule Nanotech (XPAR:MLINA) Common Stock: €1.50 Mil (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Common Stock?

Inmolecule Nanotech XPAR:MLINA 6 Common Stock is €1.50 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's quarterly common stock increased from . 20 (€0.00 Mil) to Dec. 2023 (€1.50 Mil) but then stayed the same from Dec. 2023 (€1.50 Mil) to Dec. 2024 (€1.50 Mil).

Inmolecule Nanotech's annual common stock increased from . 20 (€0.00 Mil) to Dec. 2023 (€1.50 Mil) but then stayed the same from Dec. 2023 (€1.50 Mil) to Dec. 2024 (€1.50 Mil).

Inmolecule Nanotech Common Stock Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Common Stock Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Common Stock
1.50 1.50

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Common Stock 1.50 1.50
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €1.50 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Common Stock of €1.50 Mil as of Dec. 2024. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Common Stock too high?
Inmolecule Nanotech's current Common Stock is €1.50 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Common Stock compare to VRTX and REGN?
Inmolecule Nanotech's Common Stock of €1.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Common Stock is €1.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Common Stock of €1.50 Mil. The current Common Stock is €1.50 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Common Stock is €1.50 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price